There were no significant differences between the development and validation sets in most comparisons of baseline data, including for sex, stage of BCLC, Child–Pugh classification, portal vessel invasion, extrahepatic metastasis, tumor number, AFP level, AST, TBIL, ALB, HB, PLT, and PNI. The gene discussed is GSTM1; the disease is neoplasm.